Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

When dormancy fuels tumour relapse
Karla Santos-de-Frutos, Nabil Djouder
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Age Related Osteoporosis: Targeting Cellular Senescence
Ursula Föger‐Samwald, Katharina Kerschan‐Schindl, Maria Butylina, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2701-2701
Open Access | Times Cited: 73
Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance
Ebrahim H. Maleki, Ahmad Reza Bahrami, Maryam Moghaddam Matin
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 189-204
Open Access | Times Cited: 62
Aging Hallmarks and Progression and Age-Related Diseases: A Landscape View of Research Advancement
Rumiana Tenchov, Janet M. Sasso, Xinmei Wang, et al.
ACS Chemical Neuroscience (2023) Vol. 15, Iss. 1, pp. 1-30
Open Access | Times Cited: 60
The senescence journey in cancer immunoediting
Alessandra Zingoni, Fabrizio Antonangeli, Silvano Sozzani, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 23
Advanced drug delivery platforms target cancer stem cells
MirAhmad Mazloomi, Abolfazl Doustmihan, Sajjad Alimohammadvand, et al.
Asian Journal of Pharmaceutical Sciences (2025), pp. 101036-101036
Open Access | Times Cited: 3
Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours
Stefania Crucitta, Federico Cucchiara, Ron H.J. Mathijssen, et al.
Cancer Treatment Reviews (2022) Vol. 104, pp. 102340-102340
Closed Access | Times Cited: 40
Dormant cancer cells: programmed quiescence, senescence, or both?
Kevin Truskowski, Sarah R. Amend, Kenneth J. Pienta
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 1, pp. 37-47
Open Access | Times Cited: 37
Quiescent Cancer Cells—A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse
Emma Lindell, Lei Zhong, Xiaonan Zhang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3762-3762
Open Access | Times Cited: 29
Cellular Dormancy in Cancer: Mechanisms and Potential Targeting Strategies
Hyeyoung Min, Ho‐Young Lee
Cancer Research and Treatment (2023) Vol. 55, Iss. 3, pp. 720-736
Open Access | Times Cited: 29
Non-lethal outcomes of engaging regulated cell death pathways in cancer
Halime Kalkavan, Sebastian Rühl, Jeremy J.P. Shaw, et al.
Nature Cancer (2023) Vol. 4, Iss. 6, pp. 795-806
Closed Access | Times Cited: 27
Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence
Muhammad Tufail, Canhua Jiang, Ning Li
Military Medical Research (2025) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Considering therapy-induced senescence as a mechanism of tumour dormancy contributing to disease recurrence
Tareq Saleh, David A. Gewirtz
British Journal of Cancer (2022) Vol. 126, Iss. 10, pp. 1363-1365
Open Access | Times Cited: 30
Insights into the role of senescence in tumor dormancy: mechanisms and applications
Valerie DeLuca, Tareq Saleh
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 1, pp. 19-35
Closed Access | Times Cited: 19
Unveiling cancer dormancy: Intrinsic mechanisms and extrinsic forces
Ruihua Liu, Yawei Zhao, Shang Su, et al.
Cancer Letters (2024) Vol. 591, pp. 216899-216899
Open Access | Times Cited: 7
Patient‐Derived Organoids as Therapy Screening Platforms in Cancer Patients
Danial Khorsandi, Jiawei Yang, Samuel Foster, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 21
Closed Access | Times Cited: 6
Long Non-Coding RNAs (lncRNAs) in Response and Resistance to Cancer Immunosurveillance and Immunotherapy
Giasemi C. Eptaminitaki, Nora Wolff, Dimitris Stellas, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3313-3313
Open Access | Times Cited: 34
CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status
Маргарита Пустовалова, Taisia Blokhina, Lina Alhaddad, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4922-4922
Open Access | Times Cited: 28
Nanoparticles: The future of effective diagnosis and treatment of colorectal cancer?
Reza Naeimi, Rezvan Najafi, Pejman Molaei, et al.
European Journal of Pharmacology (2022) Vol. 936, pp. 175350-175350
Closed Access | Times Cited: 25
The Osteoclast Traces the Route to Bone Tumors and Metastases
Sharon Russo, Federica Scotto di Carlo, Fernando Gianfrancesco
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 24
MicroRNA-nanoparticles against cancer: Opportunities and challenges for personalized medicine
Elisa Martino, Nunzia D’Onofrio, Camilla Anastasio, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 371-384
Open Access | Times Cited: 16
Cellular senescence in glioma
Rafał Chojak, Jawad Fares, Edgar Petrosyan, et al.
Journal of Neuro-Oncology (2023) Vol. 164, Iss. 1, pp. 11-29
Closed Access | Times Cited: 16
Polyploid/Multinucleated Giant and Slow-Cycling Cancer Cell Enrichment in Response to X-ray Irradiation of Human Glioblastoma Multiforme Cells Differing in Radioresistance and TP53/PTEN Status
Lina Alhaddad, Roman N. Chuprov‐Netochin, Маргарита Пустовалова, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1228-1228
Open Access | Times Cited: 15
Cancer Bioenergetics and Tumor Microenvironments—Enhancing Chemotherapeutics and Targeting Resistant Niches through Nanosystems
Aisha Farhana, Abdullah Alsrhani, Yusuf S. Khan, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3836-3836
Open Access | Times Cited: 13
LncRNAs and the Cancer Epigenome: Mechanisms and Therapeutic Potential
Revathy Nadhan, Ciro Isidoro, Yong Sang Song, et al.
Cancer Letters (2024) Vol. 605, pp. 217297-217297
Closed Access | Times Cited: 5
Gold Nanoconjugates for miRNA Modulation in Cancer Therapy: From miRNA Silencing to miRNA Mimics
Diana P. Sousa, João Conde
ACS Materials Au (2022) Vol. 2, Iss. 6, pp. 626-640
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top